Modern considerations of myocardial revascularization in coronary chronic total occlusion
https://doi.org/10.15829/1728-8800-2019-6-69-74
Abstract
Coronary chronic total occlusion (CTO) occurs in 16-18,4% of cases according to observational studies and registers. Traditionally, endovascular revascularization methods are considered a less appropriate strategy then drug therapy. The results of studies have shown that incomplete myocardial revascularization after unsuccessful recanalization leads to a worse long-term prognosis. Due to the accumulated experience and new technical equipment, the success rate of coronary recanalization reached 87-95%. It allows more often achieving complete myocardial revascularization and is as a reason for reconsideration and potential switching from conservative approach to active tactics in CTO. In this regard, there is a great need for randomized clinical trials to assess the efficiency of endovascular revascularization in CTO.
About the Authors
D. K. Vasiliev
https://www.gnicpm.ru/Employee/1002
National Medical Research Center for Preventive Medicine
Russian Federation
Moscow.
National Medical Research Center for Preventive Medicine
Russian Federation
Moscow.
B. A. Rudenko
https://www.gnicpm.ru/Employee/248
National Medical Research Center for Preventive Medicine
Russian Federation
Moscow.
National Medical Research Center for Preventive Medicine
Russian Federation
Moscow.
References
1. Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol 2013;61(3):282–94.
2. Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek D, et al. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention 2007;3(1):30–43.
3. Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012;59(11):991–7.
4. Ramunddal T, Hoebers LP, Henriques JP, Dworeck C, Angeras O, Odenstedt J, et al. Chronic total occlusions in Sweden—a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One 2014;9(8):e103850.
5. Brilakis ES, Banerjee S, Karmpaliotis D, Lombardi WL, Tsai TT, Shunk KA, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2015;8(2):245–53.
6. Strauss BH, Shuvy M, Wijeysundera HC. Revascularization of chronic total occlusions: time to reconsider? J Am Coll Cardiol 2014;64(12):1281–9.
7. Brilakis ES, Grantham JA, Rinfret S, Wyman RM, Burke MN, Karmpaliotis D, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv 2012;5(4):367–79.
8. Maeremans J, Walsh S, Knaapen P, Spratt JC, Avran A, Hanratty CG, et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol 2016;68(18):1958–70.
9. Nombela-Franco L, Urena M, Jerez-Valero M, Nguyen CM, Ribeiro HB, Bataille Y, et al. Validation of the J-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort. Circ Cardiovasc Interv 2013;6(6):635–43.
10. Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, Wyman RM, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol 2015;198:222–8.
11. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991;83(3):739–46.
12. Azzalini L, Dautov R, Ojeda S, Benincasa S, Bellini B, Giannini F, et al. Procedural and long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion. JACC Cardiovasc Interv 2017;10(9):892–902.
13. Tomasello SD, Boukhris M, Giubilato S, Marza F, Garbo R, Contegiacomo G, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J 2015;36(45):3189–98.
14. Stuijfzand WJ, Driessen RS, Raijmakers PG, Rijnierse MT, Maeremans J, Hollander MR, et al. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 2017;18(9): 1025–33.
15. Di Marco A, Anguera I, Teruel L, Muntane G, Campbell NG, Fox DJ, et al. Chronic total occlusion in an infarct-related coronary artery and the risk of appropriate ICD therapies. J Cardiovasc Electrophysiol 2017;28(10):1169–78. [16] Di Marco A, Paglino G, Oloriz T, Maccabelli G, Baratto F, Vergara P, et al. Impact of a chronic total occlusion in an infarct-related artery on the long-term outcome of ventricular tachycardia ablation. J Cardiovasc Electrophysiol 2015;26(5):532–9.
16. Watanabe H, Morimoto T, Shiomi H, Furukawa Y, Nakagawa Y, Ando K, et al. Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDOKyoto AMI registry). EuroIntervention 2017;12(15):e1874–82.
17. Fujii T, Sakai K, Nakano M, Ohno Y, Nakazawa G, Shinozaki N, et al. Impact of the origin of the collateral feeding donor artery on short-term mortality in ST-elevation myocardial infarction with comorbid chronic total occlusion. Int J Cardiol 2016; 218:158–63.
18. Henriques JP, Hoebers LP, Ramunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol 2016;68(15):1622–32.
19. Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen B, Ramunddal T, et al. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson 2017;19(1):53.
20. Christakopoulos GE, Christopoulos G, Carlino M, Jeroudi OM, Roesle M, Rangan BV, et al. Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol 2015;115(10): 1367–75.
21. Safley DM, Grantham JA, Hatch J, Jones PG, Spertus JA. Quality of life benefits of percutaneous coronary intervention for chronic occlusions. Catheter Cardiovasc Interv 2014;84(4):629–34.
22. Rossello X, Pujadas S, Serra A, Bajo E, Carreras F, Barros A, et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol 2016;117(5):720–6.
23. Hoebers LP, Claessen BE, Elias J, Dangas GD, Mehran R, Henriques JP. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol 2015;187:90–6.
24. Stuijfzand WJ, Biesbroek PS, Raijmakers PG, Driessen RS, Schumacher SP, van Diemen P, et al. Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function. EuroIntervention 2017;13(3):345–54. S.P. Schumacher et al. / Cardiovascular Revascularization Medicine xxx (2018) xxx–xxx 9 Please cite this article as: Schumacher SP, et al, Percutaneous coronary intervention of chronic total occlusions: When and how to treat, Cardiovascular Revascularization Medicine (2018), https://doi.org/10.1016/j.carrev.2018.07.025
25. Baks T, van Geuns RJ, Duncker DJ, Cademartiri F, Mollet NR, Krestin GP, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol 2006;47(4):721–5.
26. Galassi AR, Boukhris M, Toma A, Elhadj Z, Laroussi L, Gaemperli O, et al. Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction. JACC Cardiovasc Interv 2017;10(21):2158–70.
27. Toma A, Gebhard C, Gick M, Ademaj F, Stahli BE, Mashayekhi K, et al. Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients. EuroIntervention 2017;13(2):e228–35.
28. Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J 2018. https://doi.org/10.1093/eurheartj/ehy220 [Epub ahead of print].
29. Park S. Optimal medical therapy with or without stenting for coronary chronic total occlusion - DECISION-CTO. American College of Cardiology (ACC) Annual Scientific Sessions 2017; 2017 March 17–19 [Washington, DC].
30. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35(37):2541–619.
31. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC/ AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017;69(17):2212–41.
32. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the shortterm survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107(23):2900–7.
33. Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv 2014;83(1):9–16.
34. Galassi AR, Werner GS, Tomasello SD, Azzarelli S, Capodanno D, Barrano G, et al. Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions. J Interv Cardiol 2010;23(2):139–48.
35. Stuijfzand WJ, Raijmakers PG, Driessen RS, van Royen N, Nap A, van Rossum AC, et al. Value of hybrid imaging with PET/CT to guide percutaneous revascularization of chronic total coronary occlusion. Curr Cardiovasc Imaging Rep 2015;8(7):26.
36. Seung-Whan Lee, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. The DECISION-CTO Trial. 10.1161/CIRCULATIONAHA.118.031313
37. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394
38. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention ;
39. 2018 ESC/EACTS Guidelines on myocardial revascularization
40. Hochman JS1, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006 Dec 7;355(23):2395-407. Epub 2006 Nov 14
Review
For citations:
Vasiliev D.K., Rudenko B.A. Modern considerations of myocardial revascularization in coronary chronic total occlusion. Cardiovascular Therapy and Prevention. 2019;18(6):69-74. (In Russ.) https://doi.org/10.15829/1728-8800-2019-6-69-74
Views:
926
Email this article 
